Should more patients be offered repair for mitral valve endocarditis? a single-centre 15-year experience

Table 6 Other secondary outcomes by MV repair and replacement

	MVr (n = 85)	MVR (n = 98)	*P value
Post-operative stay, days	14 (7–33)	20 (11–37)	0.9650
Total hospital stay, days	18 (10–42)	30 (15–47)	0.9144
Thromboembolic or haemorrhagic events	5 (5.88)	7 (7.14)	0.548

Data presented are median (IQR)) or number (percentage) where appropriate
MVr mitral valve repair, MVR mitral valve replacement
^*P value was based on ANCOVA, adjusted for Logistic EuroSCORE, or Fisher’s exact test where appropriate

ISSN: 1749-8090